Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Solexa Inc.

Division of Illumina Inc.
www.solexa.com

Latest From Avidia Inc.

Financings Of The Fortnight: Corporate Venture Contributing In A Big Way

Once an unlikely scenario, corporate venture funds now are making up a larger and larger part of investment rounds for early-stage biotechs; these investments are buoyed by VCs launching their own firms. Plus news on recent financing activity from Avaxia Biologics, Clovis Oncology, Protagonist Therapeutics and Dermira.

BioPharmaceutical North America

AbbVie Joins Avaxia Board, Becomes An Early Investor In The Gut Therapy Biotech

AbbVie has been filling out its pipeline with small deals that could result in a follow-on drug to its blockbuster Humira; it’s most recent investment is in a small company doing further work in the space.

BioPharmaceutical North America

Alvine Hopes To Bring The First Celiac Drug To Market With New Partner AbbVie

Alvine and AbbVie have inked a deal that could allow the larger company to acquire the biotech based on results of a Phase IIb trial for its celiac disease treatment.

BioPharmaceutical Strategy

Biologics Swing For The Fences: Payer Perspectives On Antibodies In Primary Care

Companies with large-molecule expertise increasingly are eyeing primary care markets, confident that improvements in safety and efficacy will make them competitive with oral standards of care.

BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Nanotechnology, Chips, etc.
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Solexa Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Illumina Inc.
  • Senior Management
  • John West, CEO
    Linda Rubinstein, VP, CFO
    Simon Bennett, Dir., Bus. Dev.
    Tony Smith, VP, CSO
  • Contact Info
  • Solexa Inc.
    Phone: (510) 670-9300
    25861 Industrial Blvd.
    Hayward, CA 94545
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register